Trial Profile
Vonoprazan Study In Patients With Erosive Esophagitis to Evaluate Long-term Safety: A Study to Evaluate the Safety of Long-term Administration of Vonoprazan in Maintenance Treatment in Patients With Erosive Esophagitis (EE)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2023
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Lansoprazole
- Indications Erosive oesophagitis
- Focus Adverse reactions
- Acronyms VISION
- Sponsors Takeda
- 09 May 2023 Results assessing the effect on gastric mucosal tissue and the safety of long-term administration of vonoprazan in patients receiving maintenance treatment after healed erosive esophagitis, in comparison with lansoprazole , presented at the Digestive Disease Week 2023.
- 05 Apr 2022 Status changed from active, no longer recruiting to completed.
- 05 Apr 2022 This trial has been completed in Japan (End Date:05 Mar 2022), according to Japan Pharmaceutical Information Center - Clinical Trials Information record.